Oncology PracticeFDA approves first PARP inhibitor for early BRCA+ breast cancerMarch 15, 2022Metastatic Breast CancerBreast Cancer
Oncology PracticeHeavy drinking in your 20s has lasting impact on cancer riskMarch 10, 2022Mixed TopicsBreast CancerGastrointestinal Cancer
Oncology PracticeMRI with mammogram reduces breast cancer mortality by more than 50% in high-risk womenMarch 8, 2022Breast Cancer
Oncology PracticeOncology care model reduces cost of supportive care medsMarch 2, 2022Practice ManagementBreast CancerLung CancerGastrointestinal Cancer
Oncology PracticeShould all women be routinely screened for lung cancer?March 2, 2022Lung CancerBreast CancerMetastatic Breast Cancer
Oncology PracticeVariants of nine breast cancer genes associated with severe diseaseFebruary 24, 2022Breast Cancer
Oncology PracticePoor trial representation tied to worse breast cancer survivalFebruary 23, 2022Breast CancerDiversity in Medicine
HR-positive BC: Sulindac relieves musculoskeletal symptoms in patients receiving aromatase inhibitorsFebruary 22, 2022Breast Cancer
HER2-negative BC: Better pathological response with nab-paclitaxel vs. docetaxel in real worldFebruary 22, 2022Breast Cancer
Early breast cancer: Adding capecitabine prolongs survival in 15-year FinXX trialFebruary 22, 2022Breast Cancer
